We are live on ! Find out more
IFRX icon

InflaRx

30 hedge funds and large institutions have $10.5M invested in InflaRx in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $86K | Put options by funds: $28K

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

38% more capital invested

Capital invested by funds: $7.63M → $10.5M (+$2.91M)

11% more funds holding

Funds holding: 2730 (+3)

2.86% less ownership

Funds ownership: 11.9%9.04% (-2.9%)

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

Holders
30
Holders Change
+3
Holders Change %
+11.11%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
5
Reduced
9
Closed
3
Calls
$86K
Puts
$28K
Net Calls
+$58K
Net Calls Change
+$53K

IFRX Hedge Fund Activity: Q3 2022 in Review

30 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q3 2022, worth a combined $10.5M — up 38% from $7.63M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new IFRX positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 9 trimmed.

The largest buyer was Invesco, adding an estimated $360K. The largest seller was Suvretta Capital Management, cutting an estimated $2.56M.

  • 30 institutional investors held InflaRx (IFRX) as of Q3 2022, up from 27 in Q2 2022.
  • Funds reported $10.5M of InflaRx stock for Q3 2022, up 38% quarter-over-quarter.
  • 6 funds opened new InflaRx positions in Q3 2022 and 3 closed out, a net change of +3 holders.
  • The largest InflaRx buyer in Q3 2022 was Invesco, an estimated $360K added.
  • The largest InflaRx seller in Q3 2022 was Suvretta Capital Management, an estimated $2.56M sold.

Based on aggregated 13F filings for Q3 2022.